URGN – urogen pharma ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
UroGen Pharma says permanent J Code for ZUSDURI now in effect [Yahoo! Finance]
Urogen Pharma (NASDAQ:URGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $33.00 price target on the stock.
Permanent J Code for ZUSDURI™ Now in Effect, Expanding Patient Access to Innovative Bladder Cancer Therapy
Loss-Making UroGen Pharma Ltd. (NASDAQ:URGN) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
Billionaire Family Office Dumps All of Its UroGen Stock Amid 100% Rally [Yahoo! Finance]
Form 4 UroGen Pharma Ltd. For: Nov 26 Filed by: BUTITTA CYNTHIA M
Form 4 UroGen Pharma Ltd. For: Nov 26 Filed by: Robinson James A. Jr.
Form 4 UroGen Pharma Ltd. For: Nov 26 Filed by: WEN LEANA
Form 4 UroGen Pharma Ltd. For: Nov 26 Filed by: Wildman Daniel George
Form 4 UroGen Pharma Ltd. For: Nov 19 Filed by: Schoenberg Mark
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.